The Indian Journal of Pediatrics

, Volume 81, Issue 9, pp 866–870 | Cite as

Surgical Placement of Totally Implantable Venous Access Device–An Institutional Experience

  • Aravindan ChandrasekaranEmail author
  • Jayabose Somasundaram
Original Article



To investigate the advantages and disadvantages of Totally implantable venous access devices (TIVAD) catheter in pediatric age group and also to review this subject in the recent literature and compare the results with the present results.


A total of 61 cases, 2 mo to 14 y old, were included in the index study. TIVADs were implanted in these patients for chemotherapy. The device was inserted under general anesthesia (GA) by open technique. All the children were followed up for a mean period of 7.2 mo.


Out of 61 cases, 9 cases had complications; 3 requiring removal of the port due to infection and in one case the device had to be reinserted due to malpositioning, one had late wound dehiscence with exposed port chamber which needed operative correction and four had minor wound infections. There was no mortality. Complications like hemo or pneumothorax, arterial puncture, hematoma formation were very less with open technique of insertion of the port. Most patients and their parents were satisfied with TIVAD.


Thus, TIVAD can be a useful device for many chronic patients who need an IV access for multiple injections especially in pediatric age group.


TIVAD Pediatric life ports Long term venous access in children Port-a cath in children 


Conflict of Interest


Role of Funding Source



  1. 1.
    Araújo C, Silva JP, Antunes P, Fernandes JM, Dias C, Pereira H, et al. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. Eur J Surg Oncol. 2008;34:222–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Rouzrokh M, Shamsian BS, KhaleghNejad Tabari A, Mahmoodi M, Kouranlo J, Manafzadeh G, et al. Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases. Arch Iran Med. 2009;12:389–94.PubMedGoogle Scholar
  3. 3.
    Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998;9:767–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Ahmadi J, Izadyar M, Ashjaei B, Klantari M, Nahvi H, Joodi M, et al. Study of advantages and disadvantages of totally implantable venous access devices. Acta Med Iran. 2006;44:199–202.Google Scholar
  5. 5.
    CDC: 2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections.
  6. 6.
    Kelly MS, Conway M, Wirth KE, Potter-Bynoe G, Billett AL, Sandora TJ. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: A single institution experience of 41 cases. J Pediatr Hematol Oncol. 2013;35:e71–6.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Munro FD, Gillett PM, Wratten JC, Shaw MP, Thomas A, MacKinlay GA, et al. Totally implantable central venous access devices for paediatric oncology patients. Med Pediatr Oncol. 1999;33:377–81.PubMedCrossRefGoogle Scholar
  8. 8.
    Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, et al. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device. Eur J Cancer. 1997;33:1190–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Di Carlo I, Pulvirenti E, Mannino M, Toro A. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. Ann Surg Oncol. 2010;17:1649–56.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2013

Authors and Affiliations

  • Aravindan Chandrasekaran
    • 1
    Email author
  • Jayabose Somasundaram
    • 2
  1. 1.Department of Pediatric SurgeryMeenakshi Mission Hospital and Research CentreMaduraiIndia
  2. 2.Department of Pediatric Hematology - OncologyMeenakshi Mission Hospital and Research CentreMaduraiIndia

Personalised recommendations